A novel predictor of adverse outcomes after ST-elevation myocardial infarction: deterioration of atrioventricular conduction

Affiliations

Editorial

Gilad Margolis et al. Coron Artery Dis. 2017 Nov.

. 2017 Nov;28(7):541-542.

doi: 10.1097/MCA.0000000000000536.

¹ Department of Cardiology, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

No abstract available

Comment on

Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial.
Kosmidou I, Redfors B, McAndrew T, Embacher M, Mehran R, Dizon JM, Ben-Yehuda O, Mintz GS, Stone GW. Kosmidou I, et al. Coron Artery Dis. 2017 Nov;28(7):550-556. doi: 10.1097/MCA.0000000000000525. Coron Artery Dis. 2017. PMID: 28644212 Clinical Trial.